Jan 11, 2022 / 07:15PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Good afternoon. Welcome back. I'm Robbie Marcus, med tech analyst at JPMorgan. Very happy to introduce our next company, Becton, Dickinson. We're going to start with a presentation by Tom Polen, the CEO; and then where we're going to bring in new CFO, Chris DelOrefice, for some question and answer afterwards. But Tom, I'll turn it over to you and join you in a little bit.
Thomas E. Polen - Becton, Dickinson and Company - President, CEO & Chairman
Okay. Thank you. And as always, it's a pleasure to be here, Robbie. Today, I'm going to cover several topics that we discussed in depth at our recent Investor Day, including BD's strategy, our meaningful progress and how we're very well positioned to deliver on our longer-term targets and drive value for all stakeholders now and consistently over the years ahead.
Go to Slide 2. Before I get started, I want to remind you that I will be making some forward-looking statements today. As such, I encourage you to read the disclaimer in
Becton Dickinson and Co at JPMorgan Healthcare Conference Transcript
Jan 22, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers